Rein Therapeutics Inc. (RNTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rein Therapeutics Inc.

    NASDAQ: RNTX · Real-Time Price · USD
    1.19
    0.03 (2.59%)
    At close: Oct 03, 2025, 3:59 PM
    1.19
    0.00%
    After-hours: Oct 03, 2025, 06:21 PM EDT

    Rein Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.00 -0.62 -0.35 -0.36
    PEG Ratio
    		 -0.00 0.01 -0.16 -0.00
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.00 0.00 0.00 0.00
    P/FCF Ratio
    		 -0.00 -0.00 -0.00 -0.00
    P/OCF Ratio
    		 -0.00 -0.00 -0.00 -0.00
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a 0.01 0.00 0.00
    Quick Ratio
    		 2.38 4.17 6.46 10.69
    Current Ratio
    		 2.38 4.17 6.46 10.69
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -1.16 n/a n/a n/a
    Return on Assets
    		 -1.01 n/a n/a n/a
    Return on Invested Capital
    		 -1.13 n/a n/a n/a
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist